The evidence framework of traditional Chinese medicine injection (Aidi injection) in controlling malignant pleural effusion: A clustered systematic review and meta-analysis

医学 恶性胸腔积液 胸膜成形术 内科学 荟萃分析 胸腔积液 中医药 随机对照试验 肿瘤科 病理 替代医学
作者
Cheng-Qiong Wang,Jiao Xu,Hong Jiang,Xiao-Tian Zheng,Yan Zhang,Xiao-Rong Huang,Fei She,Teng-Yang Fan,Lin Zhan,Jihong Feng,Qihai Gong,Xue Xiao,Xiaofan Chen,Zheng Xiao
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:115: 154847-154847 被引量:6
标识
DOI:10.1016/j.phymed.2023.154847
摘要

Aidi injection (Aidi), a traditional Chinese medicine injection, is often practiced to control malignant pleural effusion (MPE). We performed a registered systematic review and meta-analysis (PROSPERO: CRD42022337611) to clarify the clinical role of Aidi in MPE, reveal optimal combinations of Aidi and chemical agents, their indications, therapeutic route and usage, and demonstrate their clinical effectiveness and safety. All randomized controlled trials (RCTs) about Aidi in controlling MPE were collected from Chinese and English databases (up to October 2022). We clustered them into multiple homogenous regimens, evaluated the risk-of-bias at outcome level using a RoB 2, extracted and pooled the data using meta-analysis or descriptive analysis, and finally summarized their evidence quality. All 56 studies were clustered into intrapleural administration with Aidi alone or plus chemical agents, and intravenous administration with Aidi for MPE. Intrapleural administration with Aidi alone displayed similar clinical responses on Cisplatin (DDP) alone. Only administration with Aidi plus DDP significantly improved complete response and quality of life, and displayed a low pleurodesis failure, disease progression, hematotoxicity, gastrointestinal and hepatorenal toxicity. For patients with moderate to massive effusion, Karnofsky Performance Status score ≥ 50 or anticipated survival time ≥3 months, Aidi (50 ml to 80 ml each time, one time each week and three to eight times) plus DDP (20 to 30 mg, 40 to 50 mg, or 60 to 80 mg each time) significantly improved clinical responses. Most results had moderate to low quality. Current evidences indicate that Aidi, a pleurodesis agent, plays an interesting clinical role in controlling MPE. Aidi plus DDP perfusion is a most commonly used regimen, which shows a significant improvement in clinical responses. These findings also provide an indication and possible optimal usage for rational drug use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hey发布了新的文献求助10
刚刚
吴小根发布了新的文献求助20
刚刚
1秒前
ljy1111完成签到,获得积分10
1秒前
大模型的应助被柏达采纳,获得10
1秒前
满怀完成签到,获得积分10
1秒前
1秒前
邱梓铭完成签到,获得积分10
2秒前
ligaft发布了新的文献求助10
2秒前
朴实的青雪完成签到,获得积分10
2秒前
tian123完成签到,获得积分10
2秒前
2秒前
JamesPei的应助被DRpeng采纳,获得10
3秒前
夙夙发布了新的文献求助10
3秒前
平淡南霜发布了新的文献求助10
4秒前
4秒前
4秒前
shiyang2014完成签到,获得积分10
4秒前
123的应助被whl采纳,获得10
5秒前
5秒前
Zero完成签到,获得积分10
6秒前
研友_VZG7GZ的应助被外向的牛排采纳,获得10
7秒前
7秒前
7秒前
7秒前
王佩洋发布了新的文献求助10
7秒前
793967195完成签到,获得积分10
8秒前
9秒前
魏凯润发布了新的文献求助10
9秒前
10秒前
于昊666完成签到 ,获得积分10
10秒前
10秒前
陌殇发布了新的文献求助20
10秒前
初景发布了新的文献求助10
10秒前
10秒前
Zero发布了新的文献求助10
10秒前
11秒前
Zoe发布了新的文献求助10
11秒前
明明如月发布了新的文献求助30
11秒前
笑点低钥匙完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
CLSI VET01S Ed7 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals 1000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
Work as a Calling 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7863642
求助须知:如何正确求助?哪些是违规求助? 9381570
关于积分的说明 20731441
捐赠科研通 7463594
什么是DOI,文献DOI怎么找? 3348202
关于科研通互助平台的介绍 2489867
邀请新用户注册赠送积分活动 2373076